Kinled Holding

Kinled Holding is a family-backed investment firm with a global presence, focusing on direct and fund investments in innovative businesses across life sciences, financial, and digital technology sectors. The firm maintains a diversified portfolio of 175 investments, with a significant portion, over 50%, dedicated to advanced medical devices, robotics, precision medicine, drug discovery, and neuromodulation. Kinled also acts as a founding partner or limited partner in 10 specialized funds, providing capital and strategic support, which collectively manage €300 million in life sciences AUM and €225 million in digital technology AUM. These extensive investments have contributed to 22 successful IPOs over three decades. The firm is primarily led by Chairman Patrick Aisher, representing the long-term backing of the Aisher family. Kinled Holding was founded in 1924 by the Aisher family.